Find Academic Supervisors

Francesca Stradolini is a Lecturer at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the Electrical Engineering Doctoral School (EDEE). She holds a PhD in Electrical Engineering from EPFL (2018), with prior education in Bio Engineering and Neuroscience from the University of Genoa (2012, 2015). Her current work focuses on R&D engineering for medical devices, emphasizing system lifecycle management, human factors engineering, and compliance with CE/FDA regulations. As an invited guest, she contributes to usability engineering education and interdisciplinary research at EPFL. PhD: IoT Bio-Electronic Multi-Panel Device for On-line Monitoring of Anaesthesia Delivery (EPFL, 2018) MSc: Bio Engineering (University of Genoa, 2015) BSc: Bio Engineering (University of Genoa, 2012) Her research spans bioelectronics, IoT-enabled medical monitoring, and electrochemical sensor development for clinical applications. Key areas include anesthesia delivery systems, wearable diagnostics, implantable devices, and human factors engineering. Her work integrates fluidic systems, noble metal nanostructures, and open-source hardware (e.g., Raspberry Pi) to address challenges in traceability, fouling mitigation, and pharmacokinetic modeling. Scientific recognition includes the Ville de Lausanne Award (2019) , EPFL Outstanding PhD Thesis Distinction (2018) , and a Best Paper Award at MOBIHEALTH (2016) . She has published extensively in journals like IEEE TBIOCAS, Sensors and Actuators B, and IEEE Sensors Journal, with collaborative studies on propofol monitoring, carbon nanoallotrope drug detection, and implantable sensor validation. Her technical expertise includes managing medical device development lifecycles, designing IoT architectures for intensive care, and optimizing electrochemical sensors for stability in undiluted biological fluids. She has contributed to conferences such as IEEE BioCAS, ISCAS, and MOBIHEALTH, focusing on translational studies in personalized medicine and 3D-printed medical systems.

• Bioelectronics
• IoT for Medical Monitoring
• Anesthesia Delivery Systems
• +3 more

John Oakey is a Professor and Graduate Coordinator in the Department of Chemical and Biomedical Engineering at the University of Wyoming, with additional affiliations to the INBRE Program, Molecular and Cellular Life Sciences Program, and Materials Science and Engineering Program. Education Postdoctoral Fellow, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School (2007–2010) Ph.D. Chemical Engineering, Colorado School of Mines (2003) M.S. Chemical Engineering, Colorado School of Mines (1999) B.S. Chemical Engineering, Penn State University (1997) Research Interests Oakey’s laboratory integrates fluid dynamics, colloidal science and materials science to understand how biological systems behave under flow, on surfaces and within complex 3-D geometries. A unifying theme is the use of microfabrication and microfluidics to create new diagnostic, prognostic and therapeutic platforms. Current thrusts include: Heterogeneous biomaterials: self-assembled particulate tissue scaffolds whose mechanical and transport properties can be temporally programmed. Inertial microfluidics: exploiting lift forces for membrane-free particle sorting, enrichment and diagnostics. Multi-temporal analysis by flow cytometry: development of closed-loop, high-throughput microfluidic cytometers for longitudinal single-cell studies. Publication Trends From 2025 back to 2010, Oakey’s articles reveal a consistent trajectory that marries fundamental physics (microtubule mechanics, inertial focusing) with translational applications (cell encapsulation, tissue scaffolds, drug delivery). Recent work (2023-2025) increasingly targets injectable granular hydrogels, single-cell therapeutic delivery and sustainable carbon-sequestering living materials, demonstrating an evolution from microscale transport phenomena to macroscopic biomedical and environmental impact. Scientific Awards No named awards are listed in the supplied text. Advising & Coordination Roles As Graduate Coordinator for the Department of Chemical and Biomedical Engineering, Professor Oakey oversees graduate program development and student mentoring. While no individual students are named, his role implies active supervision of M.S. and Ph.D. advisees in chemical and biomedical engineering. Laboratory & Teams The Oakey Research Group operates from the Energy and Environmental Research Building (EERB 435A) at the University of Wyoming. The lab enjoys R1-level research infrastructure and collaborates broadly with the Wyoming INBRE network, the Molecular and Cellular Life Sciences Program, and the Materials Science and Engineering Program.

• Microfluidics
• Microscale transport phenomena
• Tissue engineering and regenerative medicine
• +4 more

James Briscoe is a Senior Group Leader at The Francis Crick Institute in London, where he leads a research group focused on developmental biology and morphogen signaling. He previously held positions at the Medical Research Council's National Institute for Medical Research, which later became part of the Francis Crick Institute. Education: BSc in Microbiology and Virology from the University of Warwick, UK PhD from Imperial Cancer Research Fund/King's College London Postdoctoral training at Columbia University with Thomas Jessell Dr. Briscoe's research focuses on the molecular and cellular mechanisms of graded signaling by morphogens and the role of transcriptional networks in cell fate specification. His laboratory employs a range of experimental and computational techniques using model systems including mouse and chick embryos and embryonic stem cells. His work has significant implications for understanding developmental processes and their relationship to disease. His recent publications demonstrate a continued focus on morphogen gradients, neural tube development, and computational approaches to understanding cell fate decisions. His research increasingly integrates single-cell technologies and computational modeling to unravel the complexities of developmental patterning. Scientific Awards and Honors: EMBO Young Investigator (2001) EMBO Gold Medal (2008) Elected to EMBO (2009) Fellow of the Academy of Medical Sciences (2019) Fellow of the Royal Society (2019) As Editor-in-Chief of the journal Development since 2018, Dr. Briscoe plays a significant role in shaping the field of developmental biology. His leadership extends to mentoring researchers and contributing to scientific policy discussions, as evidenced by his recent publication 'Science under siege: protecting scientific progress in turbulent times.' Dr. Briscoe's laboratory at the Crick Institute is well-equipped with access to advanced facilities including light microscopy, flow cytometry, genomics, and computational resources, enabling a multidisciplinary approach to developmental biology questions.

• Developmental Biology
• Molecular Signaling
• Transcriptional Networks
• +4 more

Dr. Jeremy Guest is the Levenick Professor in Civil and Environmental Engineering (and courtesy appointment in Chemical & Biomolecular Engineering) at the University of Illinois Urbana-Champaign (UIUC). He serves as Associate Director for Research at the Institute for Sustainability, Energy, and Environment (iSEE) and leads the Center for Advanced Bioenergy and Bioproducts Innovation (CABBI). His research focuses on advancing circular bioeconomies through sustainable sanitation systems, resource recovery from wastewater, and biofuel/bioproduct development from lignocellulosic biomass. Guest's work emphasizes Quantitative Sustainable Design (QSD) methodologies to bridge engineering innovation with policy and investment decisions. Education: PhD in Environmental Engineering (University of Michigan, 2012); MS (Virginia Tech, 2007); BS (Bucknell University, 2005). Research interests include wastewater treatment innovation, nutrient recovery, bioenergy systems design, and sustainable agriculture practices. Key contributions include the EcoRecover phosphorus recovery process, the QSDsan modeling platform, and leadership in CABBI's $262.5M DOE-funded initiative. Guest has secured funding from NSF, US EPA, USDA, and the Bill & Melinda Gates Foundation. Recognitions include the NSF CAREER Award, 2021 James J. Morgan Early Career Award, and the Paul L. Busch Award. He advises over 15 graduate students and leads multiple high-impact projects like the NEWgenerator sanitation system and oilcane biorefinery integration. Lab/Group: Guest Research Group focuses on experimental, computational, and policy-oriented research to solve global sustainability challenges. Current projects address algae-based wastewater treatment, fecal sludge management in low-income regions, and precision fermentation systems development.

• Circular Bioeconomy
• Wastewater Treatment
• Resource Recovery
• +5 more

Alfred O. Hero, III is the John H. Holland Distinguished University Professor of Electrical Engineering and Computer Science and the R. Jamison and Betty Williams Professor of Engineering at the University of Michigan, Ann Arbor. He is currently on leave from the University of Michigan as a Program Director in the CISE Directorate at the National Science Foundation. His primary appointment is in the Department of Electrical Engineering and Computer Science (EECS), with secondary appointments in the Department of Biomedical Engineering and the Department of Statistics. He is also affiliated with the UM Center for Computational Medicine and Bioinformatics (CCMB), the UM Graduate Program in Applied and Interdisciplinary Mathematics (AIM), the UM Applied Physics Program, and the Michigan Institute for Data Science (MIDAS), which he co-founded from 2015-2018. Hero's research focuses on data science, developing theory and algorithms for multimodality data collection, fusion, analysis and visualization that use statistical machine learning and distributed optimization. His work has applications in wearable technologies for personalized health and predictive medicine, spatio-temporal networks in biology, climate, and social discourse, anomaly detection, and data analysis for international security. His recent research interests include high dimensional spatio-temporal data analysis, multimodal data integration, statistical signal processing, and machine learning, with particular emphasis on predictive mathematical models for biological and physical sciences, social networks, network security and forensics, and personalized health and disease. His recent publications demonstrate a strong focus on high-dimensional statistical methods, contrastive learning, neural network optimization, change detection in temporal graphs, and applications in microbiome analysis and epidemic modeling. The research spans theoretical foundations in information theory and statistical learning while addressing practical applications across multiple domains. Scientific Awards: IEEE Signal Processing Society Best Paper Award (1998) Best Original Paper Award from Journal of Flow Cytometry (2008) Best Magazine Paper Award from IEEE Signal Processing Society (2010) SPIE Best Student Paper Award (2011) IEEE ICASSP Best Student Paper Award (2011) IEEE Signal Processing Society Technical Achievement Award (2014) IEEE Signal Processing Society Society Award (2015) IEEE Fourier Award (2020) University of Michigan Distinguished Faculty Achievement Award (2011) Hero has advised over 60 PhD students and 30 postdocs in areas including modeling, computation, and inference for large scale time varying data in the biosciences. He has received significant research funding from the Department of Energy, Army Research Office, Air Force Office of Scientific Research, and National Science Foundation. He has held leadership positions including President of the IEEE Signal Processing Society (2006-2007), Director of Division IX (Signals and Applications) on the IEEE Board of Directors (2009-2011), and Chair of the Committee on Applied and Theoretical Statistics of the US National Academies (2018-2020).

• Data Science
• Statistical Machine Learning
• Distributed Optimization
• +7 more

Dr. Jose Perdomo is a Research Fellow at the Central Clinical School, Sydney Medical School, within the Faculty of Medicine and Health at the University of Sydney. He is based at the Charles Perkins Centre, where his research focuses on endothelial damage, immune complex-driven thrombosis, and platelet formation mechanisms. His work employs techniques such as flow cytometry, microfluidics, and intravital microscopy. Dr. Perdomo holds a PhD from the University of Sydney’s School of Molecular and Microbial Biosciences and received a Vice-Chancellor’s Fellowship. His research has led to two international patents and recognition, including 1st prize in the 2020 China Shenzhen Innovation Competition. His studies explore targeted inhibitors to prevent immune complex formation and thrombosis, with applications in cardiovascular health. His research interests include the interplay between white blood cells, endothelial cells, and platelets, with a focus on desialylation, apoptosis, and NETosis in immune thrombocytopenia. He has contributed to understanding vaccine-induced immune thrombocytopenia and thrombotic complications post-myocardial infarction. His findings have been featured in Nature Communications , Blood Advances , and other high-impact journals. Awards: 1st prize in China Shenzhen Innovation Competition (2020). Labs/Teams: Charles Perkins Centre, University of Sydney. Grants: Vice-Chancellor’s Fellowship (University of Sydney). Media Contributions: Insights into AstraZeneca vaccine-related blood clots featured in The Guardian , SMH , and ABC News.

• Thrombosis
• Hematology
• Immunology
• +3 more

Torben Barington is a Clinical Professor at the Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, and a Consultant at the Department of Clinical Immunology, Odense University Hospital. He has held this position since August 2001 and continues to be actively involved in research, teaching, and clinical leadership. MD, University of Copenhagen, 1987 Doctoral Thesis (dr.med.), University of Copenhagen, 1996 Specialist in Clinical Immunology, 1998 His research focuses on cellular immunotherapy of cancer , particularly using CAR T-cell and CAR NK-cell technologies, primary immunodeficiencies , and the B-lymphocyte repertoire and immunoglobulin genes . His work bridges fundamental immunology with clinical applications in oncology and immunodeficiency disorders. His recent publications (2024–2025) highlight advancements in CAR T/NK-cell characterization, cytotoxicity assays, clinical translation, and tumor microenvironment interactions. These works reflect a strong trend toward translational immunology , with emphasis on personalized cancer therapy , single-cell technologies , and clinical trial development . Scientific Awards: Aage og Edith Dyssegaards Fonds æreslegat (1993) Silver Medal, University of Copenhagen (1981) He has supervised over 30 thesis students and currently mentors several graduate students in CAR-based cancer immunotherapies. He serves as an examiner for PhD defenses at both the University of Southern Denmark and the University of Copenhagen. He is also actively involved in national scientific leadership, including as Chairman of the Scientific Committee of the Danish Blood Donor Organization since 2011 and as a member of the Advisory Board for Clinical Immunology in the Region of Southern Denmark since 2007. His research is conducted in collaboration with multidisciplinary teams focusing on cellular immunotherapy , clinical immunology , and translational hematology , often in partnership with Odense University Hospital and national blood and immunology networks.

• Clinical Immunology
• Cellular Immunotherapy
• CAR T-cell Technology
• +6 more

Caetano Reis e Sousa is a Professor of Immunology at Imperial College London and Senior Group Leader/Assistant Research Director at the Francis Crick Institute. He leads the Immunobiology Laboratory, focusing on dendritic cell biology, immune responses to pathogens, and cancer immunotherapy. His research explores how dendritic cells detect pathogens and dying cells, triggering adaptive immunity. Key roles include investigating cross-presentation mechanisms, C-type lectin receptors (e.g., DNGR-1), and vaccine development strategies. Education: BSc (Hons) Biology from Imperial College London (1989), DPhil in Immunology from University of Oxford (1992). Postdoctoral training at NIH under Ron Germain. Career milestones include founding the Immunobiology Lab at CRUK London Research Institute (1998–2015) before joining the Crick. Awards & Recognition: Highly Cited Researcher (Thomson Reuters), BD Biosciences Prize (2002), Liliane Bettencourt Award (2008), Louis-Jeantet Prize (2017), Fellowships at Royal Society (2019), Academy of Medical Sciences (2006), and EMBO (2006). Named Officer of the Order of Sant'Iago da Espada (Portugal, 2009). Research Themes: Dendritic cell activation pathways, cross-presentation of tumor antigens, microbiome-cancer immunity links, and immune evasion mechanisms. Collaborations involve institutions like UCL, King's College London, and global health networks. Labs/Teams: Head of Immunobiology Lab at Crick, with expertise in immunology, cell biology, and virology. Facilities include Flow Cytometry, Genomics, and Light Microscopy cores. Active in pandemic response (e.g., SARS-CoV-2 testing initiatives).

• Immunology
• Infectious Disease
• Cancer Immunotherapy
• +3 more

Christopher Buckley is the Kennedy Professor of Translational Rheumatology and Director of Clinical Research at the Kennedy Institute of Rheumatology, University of Oxford. He holds concurrent roles as Director of NIHR Infrastructure for Birmingham Health Partners. His research focuses on fibroblast biology in rheumatoid arthritis (RA), stromal cell interactions, and translational medicine approaches to stratified therapy. He leads the Arthritis Therapy Acceleration Programme (A-TAP), advancing precision medicine strategies for immune-mediated inflammatory diseases. Educations: BSc Biochemistry, University of Oxford (1985) MBBS Medicine, Royal Free Hospital, London (1990) DPhil in Molecular Medicine (Wellcome Trust Fellowship) under Prof. John Bell (Oxford) Research Interests: Pathogenic fibroblast subpopulations in RA and systemic sclerosis Tissue-resident memory T cells in chronic inflammation Spatial transcriptomics of synovial and tendon tissues Pro-resolving fibroblast networks during inflammation resolution Development of biomarkers for disease flare/remission Awards & Leadership: MRC Senior Clinical Fellowship (2001) Arthritis Research UK Professorship (2002) Director, Birmingham NIHR Clinical Research Facility (2012-2017) Key Projects: Leading A-TAP's stratified pathology approach for drug development Investigating Wnt signaling in stromal inflammation Developing cellular atlases of joints using spatial transcriptomics

• Rheumatology
• Inflammatory Diseases
• Fibroblast Biology
• +3 more

Montserrat Anguera, Ph.D. is an Associate Professor in the Department of Biomedical Sciences at the University of Pennsylvania's School of Veterinary Medicine. Her research focuses on epigenetic mechanisms of gene regulation underlying sex differences in development and disease, with particular emphasis on X-chromosome inactivation (XCI) and its implications for female-biased autoimmune disorders. Dr. Anguera investigates how gene expression from the X-chromosome is regulated to ensure dosage compensation between males and females, and how these mechanisms become altered in diseases exhibiting sex-bias. Her laboratory has established novel epigenetic pathways involving the X-chromosome that impact human development, immune responses, and lymphocyte function. She employs advanced techniques including RNA/DNA fluorescence in situ hybridization, immunofluorescence, and allele-specific RNA sequencing to achieve single-cell resolution of epigenetic characteristics of the inactive X chromosome. Her research reveals a consistent focus on the intersection of X-chromosome biology and immunology, particularly regarding sex-biased autoimmune diseases like systemic lupus erythematosus. Key findings include the discovery that lymphocytes maintain X-chromosome inactivation differently than other somatic cells, with the inactive X exhibiting euchromatic features in female lymphocytes that may underlie female bias in autoimmune disorders. She coined the term 'dynamic XCI maintenance' to describe how T and B cells relocalize Xist RNA and heterochromatic marks to the inactive X chromosome following antigen-mediated stimulation. Dr. Anguera's laboratory includes postdocs Katherine Forsyth and Nikhil Jiwrajka, research specialist Zowie Searcy, graduate students Isabel Sierra and Natalie Toothacre, postdoctoral researcher Nuriban Valero-Pacheco, and PhD student Emma Welter. Together, they investigate epigenetic regulation of X-linked genes in development and disease contexts. She is an active member of multiple prestigious research institutes at Penn, including the Epigenetics Institute, Institute for Immunology, Center for Research on Reproduction & Women's Health, and Institute for Regenerative Medicine. Her work bridges epigenetics, immunology, and developmental biology, providing novel insights into mechanisms underlying female-biased autoimmune disorders.

• Epigenetics
• X-Chromosome Inactivation
• Long Noncoding RNAs
• +6 more

Dr. Channakeshava S. Umeshappa is a faculty member in the Department of Microbiology & Immunology and Department of Pediatrics at Dalhousie University, Canada . He holds a PhD in Immunology from the University of Saskatchewan and completed postdoctoral training at the University of Calgary. Education : DVM (Karnataka Veterinary Animal and Fisheries Sciences University, India), MVSc (Indian Veterinary Research Institute, India), PhD (University of Saskatchewan, Canada) Research Interests : Dr. Umeshappa’s program focuses on immunoregulation in chronic diseases , particularly autoimmunity and cancer. His lab employs genetically modified murine models , omics , synthetic biology , flow cytometry , and imaging to develop immunotherapies. His work emphasizes interdisciplinary collaboration with clinicians and scientists. Article Trends : Recent publications highlight nanomedicine applications in autoimmune liver disease (e.g., peptide-MHC nanomedicines, invariant NKT cell reprogramming) and cancer therapy (e.g., laser-responsive nanoparticles, tumor-to-lymph gels). Studies span immuno-informatics , cell signaling , and clinical outcomes analysis.

• Human Immunology
• Inflammation
• Autoimmunity
• +3 more

Dr. John M. Ruter is the Allan M. Armitage Professor and Director of the UGA Trial Gardens within the College of Agricultural & Environmental Sciences at the University of Georgia. His work integrates plant breeding, genetics, and sustainable nursery crop production, focusing on ornamental plants for southeastern landscapes. Education: B.S. in Ornamental Horticulture, California Polytechnic State University (1984) M.S. in Ornamental Horticulture and Landscape Design, University of Tennessee (1986) Ph.D. in Horticultural Science, University of Florida (1989) Research interests include developing climate-resilient ornamental plants (e.g., Camellia oleifera , hibiscus, crape myrtle), mutation breeding via gamma irradiation, and optimizing nursery production systems. Recent projects focus on polyploid conifer evaluation and tea oil crop development for the southeastern U.S. Recent publications highlight advancements in induced mutagenesis (EMS, gamma irradiation), disease resistance screening (Cercospora leaf spot), and genetic characterization of native and ornamental species. Key subfields include ornamental breeding , genomic analysis , and sustainable production practices . As Director of the UGA Trial Gardens, he leads plant evaluation programs that inform regional landscaping decisions and cultivar development.

• Ornamental Plant Breeding
• Nursery Crop Production
• Plant Genetics
• +4 more

Hector Aguilar-Carreno is a Professor of Virology in the Department of Microbiology and Immunology at Cornell University's College of Veterinary Medicine, where he also serves as Associate Vice Provost in the Office of the Vice President for Research and Innovation. His research focuses on high-mortality paramyxoviruses including Nipah virus (NiV) and Hendra virus (HeV), as well as coronaviruses and other enveloped viruses. Dr. Aguilar-Carreno received his BS in Biochemical Engineering from Instituto Tecnologico de Tepic, Mexico, followed by an MS in Biology from California State University, Los Angeles, and a PhD in Biochemistry and Molecular Biology from the University of Southern California. He completed postdoctoral training in Virology at UCLA under Dr. Benhur Lee before becoming an Assistant Professor at Washington State University's Paul G. Allen School for Global Animal Health. His research spans four main areas: (1) Viral entry mechanisms, where his lab has identified novel domains in viral glycoproteins important for membrane fusion; (2) Viral egress, using multi-omics approaches to study viral assembly and budding; (3) Vaccine development using viral-like particles to generate neutralizing antibodies; and (4) Antiviral discovery targeting enveloped viruses. His lab employs innovative techniques including Flow Virometry and Raman Spectroscopy to study viral entry processes. Analysis of his recent publications reveals a strong focus on paramyxoviruses (particularly Nipah and Hendra viruses), coronavirus research, and the development of broad-spectrum antivirals. His work spans fundamental virology to translational applications, with numerous publications in high-impact journals including Nature, Science, and Cell Reports. President Elect of the American Society of Virology Chair of the American Society of Virology Diversity, Equity, and Inclusion committee Chair of the Cornell CVM Diversity Committee Director of the Cornell Program for Achieving Career Excellence Chair of 16 PhD student thesis committees Dr. Aguilar-Carreno has served on numerous scientific committees including the American Society for Virology Education Committee, the American Society of Microbiology Committee for Minority Education, and as a Standing Member of the VIR-A NIH study section. His leadership extends to chairing the Cornell CVM Diversity Committee and serving on the Cornell presidential postdoctoral fellowship committee, demonstrating significant commitment to diversity and mentorship in science.

• Virology
• Paramyxoviruses
• Viral Entry Mechanisms
• +7 more

Ralph Jimenez is an Adjunct Professor of Chemistry and Institute Fellow at JILA, University of Colorado Boulder. He holds a Ph.D. from the University of Chicago (1996) and completed postdoctoral work at the University of California, San Diego (1997-1998), followed by research at The Scripps Research Institute (1998-2003). His research focuses on quantum spectroscopy and photophysics of fluorescent proteins, leveraging quantum optics to enhance spectroscopic sensitivity and developing genetically encoded biomarkers with improved photophysical properties. Key achievements include fluorescence-lifetime-based methods to engineer brighter fluorescent proteins and machine-learning approaches to improve photostability. His awards include the Arthur S. Flemming Award (2017) and U.S. Department of Commerce Gold Medal (2017). His group's work integrates quantum engineering with biophysical studies, targeting real-world applications in molecular imaging and materials science. The Jimenez Group operates labs at JILA (B117, B119, B121) and collaborates on projects involving entangled photons, two-photon absorption, and ultrafast spectroscopy. Research themes include quantum-enhanced spectroscopy for complex systems and overcoming limitations in fluorescent protein imaging through physical chemistry strategies. His lab develops novel instrumentation, including microfluidic sorting systems and tabletop X-ray spectroscopy platforms, to advance biomarker engineering and environmental monitoring.

• Quantum Science
• Spectroscopy
• Photophysics
• +3 more

Bingzhang Chen is a Senior Lecturer in the Department of Mathematics and Statistics at the University of Strathclyde, Faculty of Science. He previously held positions as a Chancellor’s Fellow at the same institution, a researcher at the Japan Agency of Marine-Earth Science and Technology (JAMSTEC), and was affiliated with Xiamen University and Mount Allison University. His academic journey began with a PhD from the Hong Kong University of Science and Technology. Education: PhD in Trophic interactions within the microbial food web, Hong Kong University of Science and Technology (Awarded 2009) His primary research interests lie at the intersection of biological oceanography and theoretical ecology, with a strong focus on ecosystem modeling. He investigates how biodiversity, particularly of phytoplankton, influences marine ecosystem functioning such as primary production and the biological carbon pump. A central theme in his work is understanding the differential temperature sensitivity between autotrophs and heterotrophs, a question that bridges statistical analysis, metabolic theory, and Earth system science. His recent publications highlight a consistent trend in developing and applying individual-based models (e.g., PIBM 1.0), analyzing large datasets on plankton thermal responses, and studying the impacts of climate change and anthropogenic activities (like nutrient input) on marine microbial communities across diverse regions from the South China Sea to the North Pacific and Scottish coastal waters. His work often combines modeling with observational data to address fundamental ecological questions. Scientific Awards: David Cushing Prize (2015) from the Journal of Plankton Research New Century Excellent Talent (2012) from the Ministry of Education of China Dr. Chen is actively involved in research supervision, currently guiding five PhD students. He has been the Principal Investigator on multiple research projects funded by organizations such as the Leverhulme Trust, FILAMO, and the National Science Foundation. His expertise in programming (R, Fortran, MATLAB) underpins his methodological approach. He also contributes to the scientific community as an Associate Editor for the prestigious journal Limnology and Oceanography . His work is associated with efforts to understand and model invasive species dynamics, such as the spread of Sargassum muticum in Scottish waters, and he is involved with external advisory groups like the MASTS Marine Artificial Intelligence Forum.

• Biological oceanography
• Theoretical Ecology
• Ecosystem modeling
• +9 more